Skip to main content
See every side of every news story
Published • loading... • Updated

Stem Cell Screening Platform Hunts for Drugs to Halt Cardiac Fibrosis

Summary by BIOENGINEER.ORG
Scientists at Stanford University have unveiled a detailed laboratory protocol for a high-throughput drug screening platform designed to find compounds capable of treating cardiac fibrosis, the stiffening of heart tissue that accompanies heart attacks, genetic cardiomyopathies, diabetes and aging. Writing in Nature Protocols, the team led by Hao Zhang and Joseph C. Wu describes a […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BIOENGINEER.ORG broke the news on Thursday, September 24, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal